Health Equals Wealth in Hungary
Chronic underfinancing is a common pitfall for many former socialist states and Hungary is no exception. Total health spending ultimately accounted for 8.0 percent of GDP in Hungary in 2014, which…
Patrick is the managing editor of PharmaBoardroom, writing and editing stories on all things healthcare and the life sciences. The holder of a Master's Degree in International Relations, Patrick has contributed to over 40 country reports and is a fluent Mandarin speaker.
Chronic underfinancing is a common pitfall for many former socialist states and Hungary is no exception. Total health spending ultimately accounted for 8.0 percent of GDP in Hungary in 2014, which…
Hungary has long boasted a vibrant, skilled pharmaceutical industry that continues to attract the interest of local and multinational entities alike. This fact was highlighted today at the celebration of GlaxoSmithKline’s…
Thailand has long been an active participant in vaccine R&D and is increasingly aware of the importance of self-reliance in vaccine production. Through government support and regional cooperation, Thailand is…
At first glance, with only 800 students, Ponce Health Sciences University (PHSU) may seem like just another medical school in Puerto Rico. But upon closer inspection, one realizes that this…
Thailand’s healthcare system has been a shining example to its neighbours and ensures all Thai citizens have access to nearly-free basic coverage. However, the system has strained public finances and…
Thailand, with its modern and relatively cheap healthcare, has become a major destination for medical tourism. This trend brings billions of dollars into the Thai economy but the higher wages…
Many of Puerto Rico’s companies, large and small, are exporting. This brings the territory a level of international competitiveness which it might not otherwise obtain. But it also calls for…
As healthcare costs are on average 40 percent cheaper in Puerto Rico compared to the mainland US, the island offers plenty of opportunities for treating patients, both from the mainland…
Local flagship company Boryung has found success with its newly developed angiotension receptor blocker (ARB) Kanarb. Nine molecules currently exist worldwide in this category of antihypertensives, and Kanarb is currently…
How quickly can a country truly transform its healthcare system, while making it sustainable for the future? The mindset of Emiratis is that anything that is feasible and beneficial for…
“Cost containment measures are not just a Polish story, but a European reality,” says Marcin Hanczaruk, general manager at Amgen. “The Reimbursement Act is a real revolution, but it has…
“Over the past twenty years, we have seen a drastic change in the socio-economic climate of the Gulf region and neighboring countries. There has been considerable growth in terms of…
See our Cookie Privacy Policy Here